Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
According to MBA MD Andrew Blauvelt, the development of oral biologics and early treatment to replace the disease is a possibility.
Read Full NewsA novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.
Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.
Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.
Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.
A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.
People with intellectual disabilities who have physical health problems or sensory impairments face a higher risk for challenging behaviours.
Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.
1.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
2.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
3.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
4.
Inner Thoughts of Leonard Bernstein, the "Maestro".
5.
PSA Screening Overdiagnosis Rises Sharply With Age
1.
Generative AI for Adaptive Oncology Trial Design
2.
Transformative Frameworks in Oncology for Better Care
3.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
4.
Understanding the Importance of Red Cell Distribution Width (RDW) in Blood Tests
5.
Tumor Evolution Forecasting for Precision Oncology Decisions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
4.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge